ROQUEFORT THERAPEUTICS PLC
ROQ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMDQ2T15
- LEI:
- 254900P4SISIWOR9RH34
- Country:
- United Kingdom
- Address:
- 85 Great Portland Street, W1W 7LT London
- Website:
- https://www.roquefortplc.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Roquefort Therapeutics is a biotechnology company focused on developing first-in-class, next-generation medicines for hard-to-treat cancers. The company's portfolio consists of five novel, patent-protected, pre-clinical programs targeting the high-growth immuno-oncology market, with a specific focus on cancers resistant to existing therapies. Operating a scalable and cost-effective distributed R&D model, Roquefort Therapeutics leverages its in-house expertise, access to state-of-the-art laboratory facilities, and a network of partnerships with leading academic cancer research centers. Founded in 2020, the company aims to advance its complementary portfolio of anti-cancer medicines through pre-clinical development.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for ROQUEFORT THERAPEUTICS PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-07 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 24.3 KB | |
| 2025-06-30 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 24.4 KB | |
| 2025-06-27 08:00 |
M&A Activity
Lyramid SPA Extension
|
English | 14.1 KB | |
| 2025-06-26 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Results of AGM
|
English | 25.0 KB | |
| 2025-06-02 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting
|
English | 10.3 KB | |
| 2025-05-23 08:00 |
Capital/Financing Update
Extension of Convertible Loan Notes
|
English | 11.9 KB | |
| 2025-05-20 08:50 |
Annual Report (ESEF)
2024 Annual Report
|
English | 1.8 MB | |
| 2025-05-20 08:50 |
Annual Report
2024 Annual Report
|
English | 3.9 MB | |
| 2025-03-14 08:00 |
Capital/Financing Update
Private Placing and Conversion of CLNs
|
English | 14.5 KB | |
| 2025-03-10 08:30 |
Board/Management Information
Board Changes
|
English | 14.4 KB | |
| 2025-03-10 08:00 |
M&A Activity
Proposed Sale of Oncogeni Ltd
|
English | 13.5 KB | |
| 2025-03-04 08:00 |
Regulatory News Service
Update on Sale of Lyramid
|
English | 15.0 KB | |
| 2025-02-04 11:58 |
Director's Dealing
Director/PDMR Shareholding
|
English | 35.8 KB | |
| 2025-02-03 08:00 |
Regulatory News Service
Share Purchase Agreement Signed - Sale of Lyramid
|
English | 21.5 KB | |
| 2025-01-02 08:00 |
M&A Activity
Proposed Sale of Midkine Portfolio
|
English | 16.2 KB |
Automate Your Workflow. Get a real-time feed of all ROQUEFORT THERAPEUTICS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ROQUEFORT THERAPEUTICS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
